KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Return on Invested Capital (2019 - 2025)

Historic Return on Invested Capital for Castle Biosciences (CSTL) over the last 7 years, with Q3 2025 value amounting to 0.05%.

  • Castle Biosciences' Return on Invested Capital fell 500.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.02% for FY2024, which is 1900.0% up from last year.
  • According to the latest figures from Q3 2025, Castle Biosciences' Return on Invested Capital is 0.05%, which was down 500.0% from 0.05% recorded in Q2 2025.
  • Castle Biosciences' 5-year Return on Invested Capital high stood at 0.02% for Q4 2024, and its period low was 0.25% during Q2 2023.
  • Its 5-year average for Return on Invested Capital is 0.1%, with a median of 0.08% in 2021.
  • As far as peak fluctuations go, Castle Biosciences' Return on Invested Capital crashed by -1500bps in 2023, and later surged by 2300bps in 2024.
  • Quarter analysis of 5 years shows Castle Biosciences' Return on Invested Capital stood at 0.08% in 2021, then plummeted by -130bps to 0.18% in 2022, then fell by 0bps to 0.18% in 2023, then soared by 109bps to 0.02% in 2024, then tumbled by -399bps to 0.05% in 2025.
  • Its last three reported values are 0.05% in Q3 2025, 0.05% for Q2 2025, and 0.07% during Q1 2025.